ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

WVE Wave Life Sciences Ltd

6.14
0.26 (4.42%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Wave Life Sciences Ltd WVE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.26 4.42% 6.14 14:00:10
Open Price Low Price High Price Close Price Previous Close
5.93 5.90 6.3799 6.14 5.88
more quote information »

Recent News

Date Time Source Heading
02/5/202422:30GLOBEWave Life Sciences First Quarter 2024 Financial Results..
30/4/202422:30GLOBEWave Life Sciences Announces Approval of First Clinical..
23/4/202422:30GLOBEWave Life Sciences Announces Continued Momentum in GSK..
27/3/202423:30GLOBEWave Life Sciences to Present at Upcoming Investor..
06/3/202423:55EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202423:39EDGAR2Form 8-K - Current report
06/3/202423:30GLOBEWave Life Sciences Reports Fourth Quarter and Full Year 2023..
29/2/202400:30GLOBEWave Life Sciences Fourth Quarter and Full Year 2023..
28/2/202400:30GLOBEWave Life Sciences Announces Upcoming Presentations at MDA..
13/2/202408:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202411:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202411:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202411:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202400:11EDGAR2Form 8-K - Current report
09/1/202400:00GLOBEWave Life Sciences Highlights Recent Achievements and..
05/1/202408:07EDGAR2Form 8-K - Current report
04/1/202400:30GLOBEWave Life Sciences to Present at 42nd Annual J.P. Morgan..
16/12/202300:36EDGAR2Form 8-K - Current report
16/12/202300:30GLOBEWave Life Sciences Announces Initiation of Dosing in Phase 2..
08/12/202322:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/12/202313:26EDGAR2Form 8-K - Current report
07/12/202323:00GLOBEWave Life Sciences Prices $100 Million Public Offering of..
07/12/202308:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/12/202308:10GLOBEWave Life Sciences Announces Proposed Public Offering of..
07/12/202308:08GLOBEWave Life Sciences Announces Initiation of Dosing in..
23/11/202300:30GLOBEWave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI..
10/11/202308:27EDGAR2Form 8-K - Current report
10/11/202300:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/11/202300:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202323:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:39EDGAR2Form 8-K - Current report
09/11/202323:30GLOBEWave Life Sciences Reports Third Quarter 2023 Financial..
04/11/202307:05GLOBEWave Life Sciences Third Quarter 2023 Financial Results..
02/10/202322:31EDGAR2Form 8-K - Current report
29/9/202306:15GLOBEWave Life Sciences Highlights Growth Strategy for Building..
25/9/202322:30GLOBEWave Life Sciences to Present at the Chardan 7th Annual..
06/9/202322:30GLOBEWave Life Sciences to Present at the H.C. Wainwright 25th..
06/9/202306:05EDGAR2Form 8-K - Current report
05/9/202321:30GLOBEWave Life Sciences Announces Submission of First Clinical..
24/8/202311:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202306:55EDGAR2Form 144 - Report of proposed sale of securities
10/8/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202307:01EDGAR2Form 8-K - Current report
03/8/202321:56EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202321:37EDGAR2Form 8-K - Current report
03/8/202321:30GLOBEWave Life Sciences Reports Second Quarter 2023 Financial..
27/7/202322:30GLOBEWave Life Sciences Second Quarter 2023 Financial Results..

Your Recent History

Delayed Upgrade Clock